Main
>
NEUROLOGY.
>
ADHD
>
Treatment
>
LisDexAmfetamine DiMesylate
>
Co.: USA. S. (Brand Cap./Patents)
>
Patent>USA Expiration: 06.01.2024
Patent>USA Expiration: 06.01.2024's products
This section has no products